Top news of the week: 25.02.2021.
Companies And Industries
Bristol Myers Inches Toward the Future of Cell Therapy with New Manufacturing Plant
BMS is looking to hire "several hundred employees over the next few years," all working to ensure the production of both their clinical and commercial cell therapies.
NovellusDx Rebrands as Fore Biotherapeutics to Tackle Unaddressed Tumor Mutations
The launch of Fore Biotherapeutics in the U.S. reflects an evolved biotech business model focused on matching patients with unaddressed tumor mutations with the right oncology medicines in ...
Forget Fast Fashion, Biotech Threads Are In | BIO
Truth be told, I’ve spent a lot of money on apparel just because it’s made from plastic bottles. I thought I was helping, until I read, Recycled Plastic is Everywhere—and It’s Harming the ...
FDA reviewer backs J&J COVID jab for emergency OK
FDA reviewers say Janssen Biotech COVID-19 vaccine has met the criteria for emergency use approval; agency advisory committee is due to review it on Friday
Could CRISPR cure HIV? US biotech Excision raises $60m to find out
US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out the viral code from human cells and ...
Moderna's CMO Zaks quits for 'next leg of his career' after swift move to commercial focus
As Moderna ramps up its COVID-19 vaccine efforts and has made one of the speediest moves from a hyped-up preclinical biotech to a commercial entity hoping to help save the world, its chief ...
Moderna sends COVID-19 booster shot for NIH testing as it hikes production targets past 2B doses
In the span of about a year, Moderna has gone from being a clinical-stage biotech with no marketed products to a key partner in the global COVID-19 vaccination effort. Now it's doubling ...
Daiichi Sankyo poaches Kite's research lead Takeshita from parent Gilead
As Daiichi Sankyo looks to cement its place as a major cancer R&D player, the Japanese Big Pharma is boosting its C-suite by nabbing a cell therapy veteran as its new global head of ...